Raymond James Financial
CRBU icon

Raymond James Financial’s Caribou Biosciences CRBU Stock Holding History

Raymond James Financial’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1K Buy
20,534
+4,161
+25% +$8.22K ﹤0.01% 5289
2026
Q1 		$31.1K Buy
+16,373
New +$28.1K ﹤0.01% 5168
2025
Q3 		– Sell
-8,727
Closed -$11K – 5338
2025
Q2 		$11K Buy
+8,727
New +$8.58K ﹤0.01% 5887

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Raymond James Financial's CRBU Position: Q2 2026 in Review

Raymond James Financial increased its Caribou Biosciences (CRBU) stake by 25% in Q2 2026, buying an estimated $8.22K and bringing the position to 20,534 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5289.

Raymond James Financial first reported a position in CRBU in Q2 2025 and has held it in 3 quarters since. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Raymond James Financial held 20,534 shares of Caribou Biosciences worth $36.1K as of Q2 2026.
  • Raymond James Financial bought 4,161 Caribou Biosciences shares in Q2 2026, an estimated $8.22K.
  • Caribou Biosciences made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5289 holding.
  • Raymond James Financial first reported a position in Caribou Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.